Idenix Pharmaceuticals (IDIX)

[rsox]

...with an approved hbv drug that may challenge the top seller in the present mkt, and will be sold world wide, plus an hcv candidate (valopicitabine) that will more than likely be a part of the future soc for hep c, plus an upcoming hiv drug about to be added to their investigations, plus their cash position along with the partnering of novartis. it would seem like a winner.